Detalhe da pesquisa
1.
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.
Genes Chromosomes Cancer
; 55(7): 601-11, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27074266
2.
MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.
Int J Cancer
; 136(12): 2844-53, 2015 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25400033
3.
Comparison of true non-contrast and virtual non-contrast images in the characterization of renal lesions using detector-based spectral CT.
Br J Radiol
; 96(1149): 20220157, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37334964
4.
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.
Cancer Immunol Immunother
; 58(7): 1085-94, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19039588
5.
KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
J Dermatol Sci
; 72(3): 284-9, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23993026
6.
MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
Pigment Cell Melanoma Res
; 22(2): 196-204, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19077144
7.
Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma.
J Invest Dermatol
; 128(11): 2696-2704, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18509361